Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 17, Issue 4, Pages 619-626
Publisher
Informa Healthcare
Online
2016-01-26
DOI
10.1517/14656566.2016.1146689
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population pharmacokinetics of nalmefene in healthy subjects and its relation to μ-opioid receptor occupancy
- (2016) Lars-Erik Broksoe Kyhl et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Alcohol use disorders
- (2016) Jason P Connor et al. LANCET
- The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis
- (2015) Kim Donoghue et al. ADDICTION
- Global statistics on addictive behaviours: 2014 status report
- (2015) Linda R. Gowing et al. ADDICTION
- A Pharmacogenetic Determinant of Mu-Opioid Receptor Antagonist Effects on Alcohol Reward and Consumption: Evidence from Humanized Mice
- (2015) Ainhoa Bilbao et al. BIOLOGICAL PSYCHIATRY
- High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial
- (2015) Christian A. Müller et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme
- (2015) Wim van den Brink et al. Expert Opinion On Drug Safety
- Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
- (2015) Michael Roerecke et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
- (2015) Matt Stevenson et al. PHARMACOECONOMICS
- Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase
- (2015) Daniel J.O. Roche et al. PSYCHONEUROENDOCRINOLOGY
- Clinical Relevance of As-Needed Treatment with Nalmefene in Alcohol-Dependent Patients
- (2015) Henri-Jean Aubin et al. EUROPEAN ADDICTION RESEARCH
- Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review
- (2015) Roberta Agabio et al. EUROPEAN ADDICTION RESEARCH
- Epidemiology ofDSM-5Alcohol Use Disorder
- (2015) Bridget F. Grant et al. JAMA Psychiatry
- Cognitive-Behavioral Treatment With Adult Alcohol and Illicit Drug Users: A Meta-Analysis of Randomized Controlled Trials
- (2015) Molly Magill et al. Journal of Studies on Alcohol and Drugs
- The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients
- (2015) Clément François et al. PLoS One
- Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence
- (2014) James C. Garbutt et al. ADDICTION
- Current pharmacological treatment approaches for alcohol dependence
- (2014) Christian A Müller et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings
- (2014) Daniel E. Jonas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study
- (2014) Wim van den Brink et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Bad medicine: nalmefene in alcohol misuse
- (2014) D. Spence BMJ-British Medical Journal
- Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies
- (2013) W. van den Brink et al. ALCOHOL AND ALCOHOLISM
- Naltrexone and Nalmefene: Any Meaningful Difference?
- (2013) Robert M. Swift BIOLOGICAL PSYCHIATRY
- Effect of Nalmefene 20 and 80 mg on the Corrected QT Interval and T-Wave Morphology
- (2013) Jørgen Matz et al. CLINICAL DRUG INVESTIGATION
- Emerging pharmacotherapies for alcohol dependence: A systematic review focusing on reduction in consumption
- (2013) Henri-Jean Aubin et al. DRUG AND ALCOHOL DEPENDENCE
- A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence
- (2013) Antoni Gual et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Nalmefene for the treatment of alcohol dependence: a current update
- (2013) Michael Soyka INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Reduction of Alcohol Consumption and Subsequent Mortality in Alcohol Use Disorders
- (2013) Michael Roerecke et al. JOURNAL OF CLINICAL PSYCHIATRY
- The role of the opioid system in alcohol dependence
- (2013) David J Nutt JOURNAL OF PSYCHOPHARMACOLOGY
- Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
- (2013) Harvey A Whiteford et al. LANCET
- Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
- (2012) Natalya C. Maisel et al. ADDICTION
- Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis
- (2012) Antonio-Javier Chamorro et al. ADDICTION BIOLOGY
- Variation inOPRM1moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment
- (2012) Henry R. Kranzler et al. ADDICTION BIOLOGY
- Recent Advances in the Discovery and Preclinical Testing of Novel Compounds for the Prevention and/or Treatment of Alcohol Use Disorders
- (2012) Daryl L. Davies et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene
- (2012) Karl Mann et al. BIOLOGICAL PSYCHIATRY
- Influence of theOPRM1A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone
- (2012) Elaine Setiawan et al. PHARMACOGENOMICS
- Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians
- (2011) Dingyan Chen et al. DRUG AND ALCOHOL DEPENDENCE
- Emerging drugs to treat alcoholism
- (2010) Michael Soyka et al. EXPERT OPINION ON EMERGING DRUGS
- In vivo characterization of the opioid antagonist nalmefene in mice
- (2010) Melissa D. Osborn et al. LIFE SCIENCES
- Compulsive alcohol drinking in rodents
- (2009) Valentina Vengeliene et al. ADDICTION BIOLOGY
- Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]diprenorphine PET study
- (2009) Tim M. Williams et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
- (2009) Rainer Spanagel PHYSIOLOGICAL REVIEWS
- Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers
- (2008) Albert J. Arias et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Drugs for relapse prevention of alcoholism: ten years of progress
- (2008) Rainer Spanagel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism
- (2008) Michael Soyka et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search